Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grain Group appears to refer most plausibly to Grain Investment Grain Group, whose legal name is Heilongjiang Liangtou Grain Group Co., Ltd., a China-based agricultural products company rather than a life sciences or biopharma company. Public company-profile sources describe it as a large-scale developer of high-end non-GMO agricultural products that integrates research, production, marketing, and standardized agricultural planting. Its business is reported to span biotechnology, production and manufacturing, tourism services, and real estate, but the available sources do not indicate a therapeutic pipeline, drug development programs, or healthcare services. Based on the available evidence, this is best classified as an active agtech/agriculture company with some biotechnology language in its description, not a healthcare-focused biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grain Group.